Differential potencies of cocaine and its metabolites, cocaethylene and benzoylecgonine, in suppressing the functional expression of somatostatin and neuropeptide Y producing neurons in cultures of fetal cortical cells

Biochemical Pharmacology

Volumn 54, Issue 4, 1997, Pages 491-500

  Aguila Mansilla, Nelson ^a   Little, Bertis B ^a   Ho, Raymond H ^b   Barnea, Ayalla ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UT Southwestern ^*  (United States)

Author keywords

Brain culture; Cocaethylene; Cocaine; Fetus; Neuropeptide Y; Somatostatin

Indexed keywords

BENZOYLECGONINE; BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; DRUG METABOLITE; HOMOCOCAINE; NEUROPEPTIDE Y; PHORBOL 13 ACETATE 12 MYRISTATE; SOMATOSTATIN;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CONTROLLED STUDY; DRUG POTENCY; FETUS; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; COCAINE; FEMALE; FETUS; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN;

EID: 0030882742     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00202-5     Document Type: Article

References (68)

1. Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA and O'Donohue TL, The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15: 1159-1181, 1985.
2. de Quidt ME and Emson PC, Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. Immunohistochemical analysis. Neuroscience 18: 545-618, 1986.
3. Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR and Polak JM, Neuropeptide Y distribution in the rat brain. Science 221: 877-879, 1983.
4. Pickel VM, Chan J and Massari VJ, Neuropeptide Y-like immunoreactivity in neurons of the solitary tract nuclei: Vesicular localization and synaptic input from GABAergic terminals. Brain Res 476: 265-278, 1989.
5. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR and Polak JM, Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241: 138-153, 1985.
6. Everitt BJ, Hokfelt T, Terenius L, Tatemoto K, Mutt V and Goldstein M, Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11: 443-462, 1984.
7. Seroogy K, Hokfelt T, Buchan A, Brown JC, Terenius L, Norman AW and Goldstein M, Somatostatin-like immunoreactivity in rat main olfactory bulb: Extent of coexistence with neuropeptide Y-, tyrosine hydroxylase-and vitamin D-dependent calcium binding protein-like immunoreactivities. Brain Res 496: 389-396, 1989.
8. McDonald AJ, Coexistence of somatostatin with neuropeptide Y, but not with cholecystokinin or vasoactive intestinal peptide, in neurons of the rat amygdala. Brain Res 500: 37-45, 1989.
9. Guy J and Pelletier G, Neuronal interactions between neuropeptide Y (NPY) and catecholaminergic systems in the rat arcuate nucleus as shown by dual immunocytochemistry. Peptides 9: 567-570, 1988.
10. Vuillet J, Kerkerian L, Salin P and Nieoullon A, Ultrastructural features of NPY-containing neurons in the rat striatum. Brain Res 477: 241-251, 1989.
11. Liposits Z, Sievers L and Paull WK, Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels. Histochemistry 88: 227-234, 1988.
12. Beal MF, Mazurek MF and Martin JB, A comparison of somatostatin and neuropeptide Y distribution in monkey brain. Brain Res 405: 213-219, 1987.
13. Toni R, Jackson IM and Lechan RM, Neuropeptide-Y-immunoreactive innervation of thyrotropin-releasing hormone-synthesizing neurons in the rat hypothalamic paraventricular nucleus. Endocrinology 126: 2444-2453, 1990.
14. Markou A and Koob GF, Postcocaine anhedonia: An animal model of cocaine withdrawal. Neuropsychopharmacology 4: 17-25, 1991.
15. Gjerris A, Widerlov E, Werdelin L and Ekman R, Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J Psychiatry Neurosci 17: 23-27, 1992.
16. Widerlov E, Lindstrom LH, Wahlestedt C and Ekman R, Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 22: 69-79, 1988.
17. Lachman HM, Papolos DF, Weiner ED, Ramazankhana R, Hartnick C, Edwards E and Henn FA, Hippocampal neuropeptide Y mRNA is reduced in a strain of learned helpless resistant rats. Mol Brain Res 14: 94-100, 1992.
18. Wahlestedt C, Karoum F, Jaskiw G, Wyatt RJ, Larhammar D, Ekman R and Reis DJ, Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc Natl Acad Sci USA 88: 2078-2082, 1991.
19. Goodman JH and Sloviter RS, Cocaine neurotoxicity and altered neuropeptide Y immunoreactivity in the rat hippocampus; A silver degeneration and immunocytochemical study. Brain Res 616: 263-272, 1993.
20. Marksteiner J and Sperk G, Concomitant increase of somatostatin, neuropeptide Y and XX glutamate decarboxylase in the frontal cortex of rats with XX decreased seizure threshold. Neuroscience 26: 379-385, 1988.
21. Bellmann R, Widmann R, Olenik C, Meyer DK, Maas D, Marksteiner J and Sperk G, Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J Neurochem 56: 525-530, 1991.
22. Marksteiner J, Sperk G and Maas D, Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat. Naunyn Schmiedebergs Arch Pharmacol 339: 173-177, 1989.
23. Beal MF, Chattha GK and Martin JB, A comparison of regional somatostatin and neuropeptide Y distribution in rat striatum and brain. Brain Res 377: 240-245, 1986.
24. Cavanagh ME and Parnavelas JG, Development of neuropeptide Y (NPY) immunoreactive neurons in the rat occipital cortex: A combined immunohistochemical-autoradiographic study. J Comp Neurol 297: 553-563, 1990.
25. Cavanagh ME and Parnavelas JG, Development of somatostatin immunoreactive neurons in the rat occipital cortex: A combined immunocytochemical-autoradiographic study. J Comp Neurol 268: 1-12, 1988.
26. 3H]cocaine recognition sites in primary cultures of mesencephalic neurons during in vitro development. J Neurochem 56: 2108-2115, 1991.
27. Rodriguez-Sanchez MN, Alvaro I and Arilla E, Effect of prenatal and postnatal cocaine exposure on somatostatin content and binding in frontoparietal cortex and hippocampus of developing rat pups. Peptides 12: 951-956, 1991.
28. Rodriguez-Sanchez MN and Arilla E, Effects of acute and chronic cocaine administration on somatostatin level and binding in the rat brain. Neuropeptides 16: 1-7, 1990.
29. Baselt RC and Cravey RH, Cocaine. In: Disposition of Toxic Drugs and Chemicals in Man, pp. 208-213. New York Medical Publishers, Inc., Chicago, IL, 1989.
30. Barnea A, Anthony E, Lu G and Cho G, Morphological differentiation of neuropeptide Y neurons in aggregate cultures of dissociated fetal cortical cells: A model system for glia-neuron paracrine interactions. Brain Res 625: 313-322, 1993.
31. Barnea A, Hajibeigi A, Cho G and Magni P, Regulated production and secretion of immunoreactive neuropeptide Y by aggregating fetal brain cells in culture. Neuroendocrinology 54: 7-13, 1991.
32. Barnea A, Cho G, Hajibeigi A, Aguila MC and Magni P, Dexamethasone induced accumulation of neuropeptide Y by aggregating fetal brain cells in culture: A process dependent on the developmental-age of the aggregates. Endocrinology 129: 931-938, 1991.
33. Barnea A, Cho G, Lu G and Mathis M, Brain-derived neurotrophic factor induces functional expression and phenotypic differentiation of cultured fetal neuropeptide Y producing neurons. J Neurosci Res 42: 638-647, 1995.
34. Magni P and Barnea A, Forskolin and phorbol ester stimulation of neuropeptide Y (NPY) production and secretion by aggregating fetal brain cells in culture: Evidence for regulation of NPY biosynthesis at transcriptional and posttranscriptional levels. Endocrinology 130: 976-984, 1992.
35. Magni P and Barnea A, An early and transient period of protein synthesis is required for induction of neuropeptide Y-mRNA by phorbol ester and forskolin in aggregate cultures of fetal brain cells. Mol Cell Endocrinol 94: 205-211, 1993.
36. Hearn WL, Flynn DD, Hime GW, Rose S, Cofino JC, Mantero-Atienza E, Wetli CV and Mash DC, Cocaethylene: A unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 56: 698-701, 1991.
37. Barnea A, Cramer O and Cho G, Truncated insulin-like growth factor - I: A potent inducer of neuropeptide Y production by aggregate cultures of fetal brain. cells. Endocr J 1: 11-17, 1993.
38. Ho RH and DePalatis LR, Substance P immunoreactivity in the median eminence of the North American opossum and domestic fowl. Brain Res 189: 565-569, 1980.
39. Labarca C and Paigen K, A simple, rapid, and sensitive DNA assay procedure. Ann Biochem 102: 344-352, 1980.
40. Settler RW, Bohman VR, Little BB, Westfall KL and Sobhi S, Metabolism of cocaine by cholinesterase during pregnancy: Maternal and fetal activity. J Maternal Fetal Med 4: 135-138, 1995.
41. Foetester EM, Dempsey J and Gariott JC, A gas chromatographic screening procedure for acid and neutral drugs in blood. J Anal Toxicol 3: 87-91, 1979.
42. Nawa H, Bessho Y, Carnahan J, Nakanishi S and Mizuno K, Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor. J Neurochem 60: 772-775, 1993.
43. Hearn WL, Rose S, Wagner J, Ciarleglio A and Mash DC, Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav 39: 531-533, 1991.
44. Tan XX and Costa LG, Inhibition of muscarinic receptor-stimulated phosphoinositide metabolism by cocaine, norcocaine and cocaethylene in rat brain. Dev Brain Res 79: 132-135, 1994.
45. Spiehler VR and Reed D, Brain concentrations of cocaine and benzoylecgonine in fatal cases. J Forensic Sci 30: 1003-1011, 1985.
46. Weiss RD and Gawin FH, Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers. Am J Med 85: 879-880, 1988.
47. Ostrea EM Jr, Brady MJ, Parks PM, Asensio DC and Naluz A, Drug screening of meconium in infants of drug-dependent mothers: An alternative to urine testing. J Pediatr 115: 474-477, 1989.
48. Bennett BA, Hyde CE, Pecora JR and Clodfelter JE, Long-term cocaine administration is not neurotoxic to cultured fetal mesencephalic dopamine neurons. Neurosci Lett 153: 210-214, 1993.
49. Hitri A, Hurd YL, Wyatt RJ and Deutsch SI, Molecular, functional and biochemical characteristics of the dopamine transporter: Regional differences and clinical relevance. Clin Neuropharmacol 17: 1-22, 1994.
50. Flynn DD, Vaishnav AA and Mash DC, Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Mol Pharmacol 41, 736-742, 1992.
51. Sharkey J, Ritz MC, Sehenden JA, Hanson RC and Kuhar MJ, Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246: 1048-1052, 1988.
52. Reith MEA, Central and peripheral cocaine binding sites. In: Cocaine: Pharmacology, Physiology, and Clinical Strategies (Eds. Lakoski JM, Galloway MP and White FJ), pp. 203-227. CRC Press, Boca Raton, FL, 1992.
53. Xu YQ, Crumb WJ Jr and Clarkson CW, Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels. J Pharmacol Exp Ther 271: 319-325, 1994.
54. Bradberry CW, Nobiletti JB, Elsworth JD, Murphy B, Jatlow P and Roth RH, Cocaine and cocaethylene: Microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem 60: 1429-1435, 1993.
55. Reith ME, Meisler BE, Sershen H and Lajtha A, Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35: 1123-1129, 1986.
56. Ritz MC, Cone EJ and Kuhar MJ, Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: A structure-activity study. Life Sci 46: 635-645, 1990.
57. Salin P, Kerkerian L and Nieoullon A, Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway. Exp Brain Res 81: 363-371, 1990.
58. Kerkerian L, Salin P and Nieoullon A, Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Neuroscience 26: 809-817, 1988.
59. Abrous DN, Le Moal M and Herman JF, The increase in striatal neuropeptide Y immunoreactivity induced by neonatal dopamine-depleting lesions in rats is reversed by intrastriatal dopamine-rich transplants. Brain Res 656: 169-173, 1994.
60. Midgley LP, Wagstaff JD, Singh NA, Bush LG, Gibb JW and Hanson GR, Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions. Eur J Pharmacol 251: 191-199, 1994.
61. Specht LA, Pickel VM, Joh TH and Reis DJ, Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogeny. J Comp Neurol 199: 233-253, 1981.
62. Specht LA, Pickel VM, Joh TH and Reis DJ, Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny. J Comp Neural 199: 255-276, 1981.
63. lacovitti L, Lee J, Joh TH and Reis DJ, Expression of tyrosine hydroxylase in neurons of cultured cerebral cortex: Evidence for phenotypic plasticity in neurons of the CNS. J Neurosci 7: 1264-1270, 1987.
64. Honegger P and Richelson E, Biochemical differentiation of aggregating cell cultures of different fetal rat brain regions. Brain Res 133: 329-339, 1977.
65. Van der Zee EA and Luiten PG, GABAergic neurons of the rat dorsal hippocampus express muscarinic acetylcholine receptors. Brain Res Bull 32: 601-609, 1993.
66. Hosli E and Hosli L, Colocalization of binding sites for somatostatin, muscarine and nicotine on cultured neurones of rat neocortex, cerebellum, brain stem and spinal cord: Combined autoradiographic and immunohistochemical studies. Neurosci Lett 173: 71-74, 1994.
67. Van der Zee EA and Luiten PG, Cholinergic and GABAergic neurons in the rat medial septum express muscarinic acetylcholine receptors. Brain Res 652: 263-272, 1994.
68. Olsen GD, Potential mechanisms of cocaine-induced developmental neurotoxicity: A minireview. Neurotoxicology 16: 159-167, 1995.